Fig. 4From: miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathwaySuppression of KIF26B inhibits tumor formation ability of HCC cells in vivo. a–d The in vivo effect of KIF26B was evaluated in xenograft mouse models bearing tumors originating from HCC-LM3 cells via tumor volume, photon flux and tumor weight; n = 6 per group. e, f Expression of KIF26B and Ki67 were detected between KIF26B shRNA and negative control groups in node mouse tumor tissuesBack to article page